H.R. 6703 (Lower Health Care Premiums for All Americans Act) makes five substantial changes to how group and individual health coverage operate. It (1) amends ERISA to create a clear statutory pathway for association health plans (AHPs) with minimum governance, eligibility, and rating rules; (2) narrows the definition of “health insurance coverage” so certain stop‑loss policies and self‑insured arrangements are not treated as insurance for some federal purposes; (3) authorizes employer-funded “custom health option” HRAs tied to individual market or Medicare coverage and adds W‑2 reporting of permitted benefits; (4) imposes broad, machine‑readable reporting obligations on pharmacy benefit managers (PBMs), including semiannual drug‑level and rebate disclosures and enforcement penalties; and (5) appropriates funding for cost‑sharing reduction (CSR) payments for plan years starting in 2027 but bars use of those funds for plans that cover abortion except in narrow cases.
Why it matters: the bill redraws regulatory lines between employers, insurers, and PBMs and creates new compliance obligations across ERISA, the Public Health Service Act, and the Internal Revenue Code. If enacted as written, employers and trade associations will get expanded access to pooled plans, PBMs will face new transparency and reporting work (and legal exposure for false reporting), and exchanges and insurers will see changes in funding and risk‑pooling incentives that could affect premiums, benefit design, and consumer protections.
At a Glance
What It Does
The bill adds a new ERISA section allowing groups or associations that meet governance, non‑discrimination, size, and existence tests to sponsor AHPs and lets self‑employed individuals participate and be treated as employers for pooling. It exempts certain stop‑loss policies from the definition of health insurance for federal purposes, creates a defined ‘custom health option’ HRA that can integrate with individual or Medicare coverage, and requires PBMs to provide detailed, machine‑readable semiannual reports to group health plans and participants. It also authorizes appropriation of CSR payments for plan years beginning in 2027 with a prohibition on using those funds for plans that cover abortion (with life‑saving/rape/incest exceptions).
Who It Affects
Employer associations and trade groups that want to offer multi‑employer plans; self‑employed individuals and small‑business owners seeking pooled coverage; health insurers and plan sponsors that contract with PBMs; PBMs, affiliated pharmacies, and rebate aggregators that will have to report contract-level and drug‑level financial flows; ERISA plan administrators and tax teams implementing HRA and W‑2 changes; and federal agencies that must write implementing rules.
Why It Matters
The bill lowers structural barriers to AHP formation and explicitly preempts certain state limits on insuring stop‑loss risk — a change likely to expand alternatives to the ACA small‑group/individual markets. Its PBM reporting regime promises unprecedented data for plan sponsors and regulators but creates new operational, privacy, and legal issues. The HRA changes and CSR appropriation further shift how premiums and cost‑sharing are financed, potentially altering who bears premium risk and how benefits are designed.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
Title I rewrites how association health plans can form and operate under ERISA. To qualify, a group or association must have existed in good faith for at least 2 years, maintain formal governance (a board or equivalent) with at least 75% employer‑member control, and offer coverage to all employees of member employers.
Membership may not be conditioned on health status. The bill treats self‑employed persons as both potential employer‑members and as employees eligible to participate; groups composed solely of self‑employed individuals must aggregate at least 20 members into a single employer member and must offer coverage to at least 51 employees overall.
The bill permits a modified community rating to set base premiums while letting plans actuarially adjust employer contributions based on each employer member’s specific risk profile; in contrast, groups made only of self‑employed individuals must pool risk and charge a single rate.
A related ERISA amendment clarifies that stop‑loss policies obtained by self‑insured plans or plan sponsors are not “health insurance coverage” for certain federal code sections, and the bill adds a preemption clause to prevent state laws from blocking employers or plans from insuring excess claims risk. That creates a clearer federal pathway for self‑insurance and stop‑loss arrangements to operate across state lines.Section 103 legalizes a class of employer‑funded HRAs called “custom health option and individual care expense arrangements” that reimburse medical care only when the employee (and dependents) carry qualifying individual market or Medicare coverage.
These arrangements must meet nondiscrimination, substantiation, and advance notice rules; employers must offer them uniformly within specified employee classes. The bill also requires W‑2 reporting of the total permitted HRA benefits for enrolled individuals, and the effective date for these changes is plan years beginning after December 31, 2025.Title II imposes a detailed PBM transparency and reporting regime across three statutory vehicles (PHSA, ERISA, and the IRC).
Effective 30 months after enactment, entities providing PBM services to group plans or issuers must deliver machine‑readable, plain‑language reports at least every six months (or quarterly at a plan’s request) containing itemized drug claims (identified by NDC), contracted compensation to PBMs and pharmacies, rebates and other remuneration paid or expected, net and gross spending, dispensing channel breakdowns, formulary placement rationales, and affiliated‑pharmacy pricing comparisons. The statute ties the reporting requirement to HIPAA and other privacy laws, limits public disclosure only to the extent reasonable, and requires regulators to write a standard format within 18 months.
Enforcement is civil: $10,000 per day for failure to report and up to $100,000 per item for knowingly false information, with narrow waiver authority for good‑faith compliance efforts.Finally, the bill appropriates unspecified sums as necessary to fund CSR payments beginning with plan years on or after January 1, 2027, but prohibits using those appropriated dollars for qualified health plans that include abortion coverage beyond life‑saving exceptions and pregnancies resulting from rape or incest. That funding clause directly conditions federal subsidy implementation on a coverage exclusion.
The Five Things You Need to Know
To qualify as an association health plan under the new ERISA Section 736, the group or association must have existed in good faith for at least 2 years and make coverage available to at least 51 employees.
The bill treats self‑employed individuals as both employer members and participants—self‑employed‑only groups must aggregate at least 20 members as a single employer member and charge a single pooled premium rate.
Entities providing PBM services must deliver machine‑readable, semiannual (or quarterly on request) reports that include drug‑level NDC data, contracted compensation to PBMs and pharmacies, rebate amounts (received or expected), and net price estimates; failure to report triggers a $10,000‑per‑day penalty and knowingly false items can incur up to $100,000 per item.
The custom HRA rules (the ‘custom health option’) require nondiscrimination, substantiation of individual market enrollment, advance written notice to eligible employees, and W‑2 reporting of total permitted benefits; these rules apply to plan years starting after Dec. 31, 2025.
The bill appropriates funds for CSR payments for plan years beginning Jan. 1, 2027, but bars those funds for qualified health plans that cover abortion except when necessary to save the mother’s life or in cases of rape or incest.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
New statutory requirements and governance for association health plans
This section creates a standalone ERISA provision that spells out when a group or association can sponsor a group health plan across industries. Key mechanics: a 2‑year existence test, a formal governance requirement (board or comparable structure) with at least 75% employer‑member control, scheduled elections (one vote per employer member), a minimum distribution requirement (coverage available to 51 employees), and a ban on conditioning membership on health‑status factors. It also requires plan fiduciaries to verify self‑employed member eligibility and allows actuarial adjustments of employer contributions while preserving nondiscrimination and pre‑existing condition protections consistent with existing PHSA rules. Practically, it gives associations a prescriptive compliance checklist and an explicit federal legal footing that plans and advisers can use when designing multi‑employer arrangements.
Stop‑loss policies carved out of the definition of health insurance and federal preemption
The bill amends ERISA and related definitions to say that certain stop‑loss policies purchased by self‑insured plans or plan sponsors are not ‘health insurance coverage’ for the relevant federal tests. It then adds a preemption clause that bars state laws to the extent they prevent a group health plan from insuring excess claims risk. That is a technical but consequential shift: it reduces the ability of states to use insurance‑type rules to restrict stop‑loss arrangements, which could expand self‑insurance across state lines, but also raises questions about how state consumer protections will apply in contested scenarios.
Permissible employer HRAs integrated with individual market coverage
This section creates a statutory definition for a ‘custom health option and individual care expense arrangement’ (an employer‑funded HRA that reimburses employees only while they carry qualifying individual market or Medicare coverage). It forces nondiscrimination across employer‑designated employee classes, requires written notices and substantiation (proof of individual coverage at plan start and ongoing), and adds W‑2 line‑item reporting of total permitted benefits. The provision also directs Treasury, HHS, and Labor to align prior HRA guidance with the new statutory rules and takes effect for plan years beginning after Dec. 31, 2025.
Comprehensive PBM reporting and enforcement regime
This is the bill’s most detailed compliance package. For contracts entered or renewed 30 months after enactment, PBMs and entities providing PBM services must deliver consistent, machine‑readable, plain‑language reports to group health plans every six months (quarterly if the plan requests). Required fields include drug-level NDCs, contracted compensation paid to PBMs and pharmacies, rebate and remuneration amounts received or expected, net vs gross spending, dispensing channel data (retail/mail/specialty), formulary placement rationales, affiliated‑pharmacy pricing comparisons, and summary documents for participants. The statute ties reporting to HIPAA privacy rules, requires HHS to define a standard format within 18 months, and creates civil monetary penalties ($10,000/day for non‑reporting, up to $100,000 per false item) with limited waiver authority for good‑faith attempts to comply.
Appropriation for CSR payments with abortion‑coverage restriction
Section 202 authorizes appropriations to fund cost‑sharing reduction payments for plan years beginning on or after Jan. 1, 2027. However, it includes an explicit limitation: appropriated amounts may not be used to make CSR payments for qualified health plans that include abortion coverage, except where abortion is necessary to save the life of the mother or the pregnancy resulted from rape or incest. That attaches a substantive coverage condition to federal CSR funding.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Employer associations and trade groups — the bill provides a clear ERISA pathway to sponsor multi‑employer AHPs across industries, enabling them to buy and pool coverage for member employers that previously could not form broadly eligible AHPs.
- Self‑employed individuals and small‑business owners — the statute explicitly treats self‑employed persons as eligible employer‑members and participants, allowing them to participate in pooled plans and potentially access lower group‑style premiums when they can join qualifying associations.
- Plan sponsors and large employers — PBM transparency gives plan sponsors granular data to evaluate PBM contracts, rebate flows, and affiliated‑pharmacy pricing, improving negotiating leverage and the ability to redesign pharmacy benefits.
Who Bears the Cost
- Pharmacy benefit managers and affiliated pharmacies — they must implement new data extraction, privacy controls, and reporting processes and face substantial civil penalties for delayed or false reporting.
- Health insurers and group plan administrators — compliance teams will need to absorb rule‑writing, contract revisions, data management, and participant notice obligations across ERISA, PHSA, and tax regimes.
- State insurance regulators and consumer protection entities — preemption language narrowing state ability to restrict stop‑loss and self‑insurance may shift oversight responsibilities to federal agencies and limit states’ enforcement tools.
Key Issues
The Core Tension
The central dilemma is between expanding flexible, lower‑cost coverage options (through AHPs, HRAs, and stop‑loss clarity) and preserving consumer protections and market stability: mechanisms that reduce premiums for some buyers can fragment risk pools, weaken benefit standards, and shift oversight from state regulators to federal rulemaking, while the PBM transparency regime imposes heavy operational costs and legal tradeoffs between disclosure and protection of proprietary or health‑information privacy.
The bill stacks aggressive deregulatory tools (broader AHP eligibility and federal protection for stop‑loss arrangements) against large new transparency mandates aimed at PBMs. That combination can lower buyers’ transaction costs and expand options, but it also invites strategic behavior: associations could design plans with narrow networks or benefit designs that reduce premiums but leave members exposed to high out‑of‑pocket risk.
The PBM reporting list is unusually granular — NDC‑level claims, contracted compensation splits, expected rebate receipts, and affiliated‑pharmacy pricing comparisons — but implementation will require complex data pipelines, legal review for proprietary and HIPAA‑protected information, and careful standardization. Agencies must choose how much to require publicly versus only to plan sponsors; the statute permits reasonable restrictions but gives regulators and plan sponsors broad access.
Another knotty issue is risk‑pool dynamics. Authorizing self‑employed pooling and employer‑level actuarial adjustments can produce lower headline premiums for some groups but also change incentives in the individual and small‑group markets.
If healthier employers or groups move into AHPs or custom HRAs displace broader employer coverage, ACA market risk pools could deteriorate. The CSR appropriation with an abortion coverage carve‑out addresses a political objective but creates operational complexity for exchanges and issuers (which plans receive CSR payments) and could generate legal challenges over conditional appropriation and anti‑discrimination norms.
Finally, the penalties for PBM noncompliance are steep; regulators will need to balance enforcement with transition periods and clear safe harbors to avoid chilling necessary contractual relationships.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.